ArticleBMC anesthesiology2025
Awake craniotomy for brain tumor resection: anesthetic management and clinical experience from a high complexity hospital in Latin America.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAwake craniotomy is the gold standard for resecting brain tumors in eloquent areas. This technique requires tailored anesthetic management to ensure patient safety and cooperation. We aimed to describe clinical characteristics, anesthetic management, and intraoperative outcomes in patients undergoing awake craniotomy at a high-complexity hospital in southwestern Colombia.
methodsWe conducted a retrospective case series. Sociodemographic, clinical, and intraoperative data were obtained from electronic medical records. Descriptive statistics were used to summarize the findings.
resultsFifteen patients underwent awake craniotomy with monitored anesthesia care using dexmedetomidine and remifentanil. All patients received a scalp block, non-opioid analgesics, and antiemetic prophylaxis. The most frequent adverse event was transient bradycardia without hemodynamic instability. No respiratory or neurological complications occurred. All procedures were successfully completed.
conclusionsAwake craniotomy under monitored anesthesia care with dexmedetomidine and remifentanil was feasible, safe, and well tolerated in this cohort. The absence of serious complications highlights the value of structured anesthetic protocols and trained multidisciplinary teams. This experience provides reference for the adoption of similar strategies in hospital settings across Latin America, where implementation of awake craniotomy remains limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.